Alsakali Equity AB

Other

FI·FIN-FSA

Newbury Pharmaceuticals AB Newbury Pharmaceuticals AB

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the full record of transactions filed by Alsakali Equity AB. Director active across 2 companies, notably Newbury Pharmaceuticals AB. Aggregated, 2 filings have been logged. The latest transaction was disclosed on 18 November 2025 — Purchase. Regulator: FIN-FSA. All data is openly available.

Declarations2 total

Executives●PurchaseNNewbury Pharmaceuticals AB27FIN-FSA

A

Alsakali Equity ABVerkställande direktör (VD)

€3,74125,859 shares@ €0.14470.0087% mcap30.3% of flow

Aktie

FI:A003T777-1·18 Nov 2025

Ideal exit: 15 Aug 2026 (T+270)

FIN-FSA ↗

Executives●PurchaseNNewbury Pharmaceuticals AB33FIN-FSA

A

Alsakali Equity ABVerkställande direktör (VD)

€8,58867,855 shares@ €0.12660.020% mcap69.7% of flow

Aktie

FI:A003T734-1·17 Nov 2025

Ideal exit: 14 Aug 2026 (T+270)

FIN-FSA ↗

2 of 2 declarations